Clinical Trial Update: Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial registry entry notes a Phase 1/2 trial evaluating tributyrin in people with Parkinson disease with cognitive impairment. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease Dementia

Drugs mentioned

• Tributyrin (tributyrin)

Snippet

Sponsor: Prabesh Kanel | Conditions: Parkinson Disease, Parkinson Disease Dementia | Phase 1, Phase 2 | Status: RECRUITING